Chartis® System

The Chartis System is a proprietary pulmonary assessment tool that enables physicians to identify those patients likely to respond to the Pulmonx Zephyr valves with a high degree of confidence.

The Chartis system provides precise flow and pressure readings for specific lobes in the lungs to assess collateral ventilation. Clinical studies outside of the US have shown that patients with low to no collateral ventilation respond best to Zephyr valve therapy.

CAUTION: The Zephyr Endobronchial Valve is an investigational device in the US, limited by US law to investigational use.
US / new visitor